bpc-157 ehlers-danlos syndrome Living with Ehlers-Danlos Syndrome
Description
3 , control group: 3C , 3E , BPC 157 group: 3D , 3F )
Histamine While not frequently observed, there have been instances where individuals have reported histamine reactions to BPC-157 during the initial stages of supplementation
Safety Profile: Common Side Effects : Injection site reactions, such as redness or swelling, are the most common
As you escalate to higher doses, larger vials become more economical
10.1016/j.febslet.2009.03.038 101 OkamotoH.IshikawaA.YoshitakeY.KodamaN.NishimutaM.FukuwatariT.et al (2003)
Each lot is independently tested for identity, purity, and mass using HPLC and mass spectrometry
